Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseTransplantation, AutologousBone and BonesHematopoietic Stem CellsWhole-Body IrradiationAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationTransplantation ConditioningHematopoiesisLiver TransplantationTransplantation ChimeraColony-Forming Units AssayBone Marrow PurgingGraft SurvivalTissue DonorsBusulfanBone Marrow DiseasesHistocompatibility TestingHistocompatibilityCyclophosphamideTransplantation, IsogeneicCell DifferentiationKidney TransplantationStromal CellsRadiation ChimeraLeukemia, Myeloid, AcuteCells, CulturedRecurrenceMice, Inbred C57BLTime FactorsCombined Modality TherapyAntigens, CD34Leukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationGranulocytesMesenchymal Stromal CellsLeukemia, MyeloidBone RemodelingImmunosuppressive AgentsRemission InductionTreatment OutcomeHematologic NeoplasmsGraft RejectionHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow NeoplasmsCell SeparationTransplantation ImmunologyT-LymphocytesGraft vs Host ReactionFlow CytometryStem Cell TransplantationImmunosuppressionLymphocyte DepletionLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationAcute DiseaseSevere Combined ImmunodeficiencyOsteogenesisChimeraGranulocyte Colony-Stimulating FactorHLA AntigensSurvival AnalysisMyelodysplastic SyndromesRetrospective StudiesLung TransplantationBone DensityCyclosporineActuarial AnalysisHematologic DiseasesAntigens, CDLymphocyte TransfusionLeukocyte CountBone ResorptionMultiple MyelomaNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsAntibodies, MonoclonalCarmustineColony-Stimulating FactorsOrgan TransplantationImmunophenotypingPancytopeniaGraft vs Tumor EffectGraft vs Leukemia EffectFollow-Up StudiesMice, Inbred BALB CCytarabineSurvival RateLymphomaCytomegalovirus InfectionsMesenchymal Stem Cell TransplantationGranulocyte-Macrophage Colony-Stimulating FactorErythropoiesis